Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
muscle weakness
MeSH D018908 - muscle weakness
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D020879:
Neuromuscular manifestations
0 Companies
0 Drugs
Success rate
D009135:
Muscular diseases
0 Companies
0 Drugs
Success rate
D010335:
Pathologic processes
0 Companies
0 Drugs
Success rate
D018908:
Muscle weakness
1 Company
1 Drug
$
Success rate
D000094222:
Dropped head syndrome
0 Companies
0 Drugs
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Merck & Co
Guanidine
Guanidine
1982-01-01
Clinical Trials
Historical Success Rate
Phase 1
75
%
3/4
Phase 2
60
%
9/15
Phase 3
18
%
2/11
Approved:
1
Overall Success rate:
8%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Merck & Co
Guanidine
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use